FDA Inspection 1084420 — Sri Rezeki S. Hadinegoro
The FDA completed an inspection of Sri Rezeki S. Hadinegoro on Feb 1, 2019 in Jakarta. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 1, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Jakarta (Indonesia)
Additional Details
Clinical Investigator (CI)